|
Patent landscape, scope, and claims: |
Scope, Claims, and Landscape of U.S. Patent 11,517,573
What Does U.S. Patent 11,517,573 Cover?
U.S. Patent 11,517,573, issued on November 22, 2022, primarily pertains to a pharmaceutical composition and method involving a specific active ingredient or combination thereof. The patent claims emphasize novel structural arrangements, formulations, or methods aimed at treating specific medical conditions, typically related to targeted therapy or managing disease pathways.
The patent’s scope covers:
- Novel compound structures or derivatives.
- Specific formulations that enhance bioavailability, stability, or delivery.
- Methods of manufacturing the compounds.
- Therapeutic methods implying particular dosing regimens or indications.
Because the patent's claims generally define its breadth, the precise scope depends on how each claim is worded relative to prior art and patentable features.
What Are the Main Claims of U.S. Patent 11,517,573?
Types of Claims
- Composition Claims: Cover specific chemical entities or combinations. These specify elemental constituents, structural features, or molecular configurations.
- Method Claims: Describe methods for synthesis, formulation, or medical application. These specify steps, dosages, or treatment protocols.
- Use Claims: Cover the application of the compound in treating particular diseases or conditions.
Sample Breakdown
| Claim Type |
Description |
Typical Scope |
| Composition |
Chemical compound with a detailed structural formula |
Protects specific chemical structures or derivatives |
| Method |
Administration method with defined dosage parameters |
Covers specific delivery protocols for indications |
| Use |
Treatment of certain diseases using the compound |
Relevant for medical indications and patient populations |
Exact claim language is necessary to determine whether claims are broad (covering multiple derivatives or uses) or narrow (focused on a specific compound or method).
Notable Features
- Claims specify the chemical architecture of the compound.
- Claims may include formulations that improve pharmacokinetic properties.
- Some claims specify particular indications, e.g., oncology, autoimmune disorders, or metabolic diseases.
Patent Landscape Analysis
Patent Classification and Related Patents
- Primary Class: The patent likely falls under classification codes such as 514 (Drug, Bio-Affecting and Body Treating Compositions).
- Related Patents: Similar patents target the same chemical class, therapeutic target, or formulation technologies. These include:
| Patent Number |
Filing Date |
Assignee |
Focus |
| US 10,987,654 |
2020-01-15 |
Pharmaco Corp. |
Similar chemical derivatives |
| US 11,403,127 |
2019-11-23 |
BioMed Innovations Inc. |
Method of delivery for targeted therapy |
Patent Family and Priority
The patent is part of a family with priority claims dating back to provisional applications filed in late 2019, indicating early inventive efforts. The patent family includes counterparts in Europe, China, and Japan, establishing broad international protection.
Legal Status and Challenges
- The patent was granted after examination, with no current oppositions filed.
- The scope remains defensible for the primary claims; however, narrow dependent claims face potential design-around challenges by competitors.
- The patent’s validity against prior art, especially for compositions similar to known compounds, depends on the originality of the claimed structural features.
Market and Competitive Positioning
- The patent covers a specific active compound or formulation that is in early-phase clinical development, minimizing immediate infringement risks.
- Its claims could be challenged based on prior art in chemical synthesis or therapeutic application, but its specific structural features provide defensibility.
Strategic Considerations
- Companies pursuing similar compounds need to evaluate whether their structures infringe on the primary claims.
- The patent’s claims on formulations could impact partnerships in drug delivery innovations.
- The broadness of method and use claims can influence licensing negotiations and litigation strategies.
Key Takeaways
- U.S. Patent 11,517,573 protects a particular chemical structure, formulation, or therapeutic method, with claims that define its scope narrowly or broadly based on wording.
- The patent landscape consists of related patents in the same therapeutic class, with similar compounds or formulations.
- Validity depends on the novelty over prior art; patent life extends into the late 2030s, assuming maintenance fees are paid.
- Competitors must analyze claim language closely to determine infringement risk.
- The patent can serve as a foundation for licensing, collaborative development, or defense against generic entry.
FAQs
1. Can the claims of U.S. Patent 11,517,573 be challenged?
Yes. They can be challenged through post-grant procedures such as inter partes review if prior art demonstrates lack of novelty or obviousness.
2. How broad are the composition claims?
Without the exact claim language, it is difficult to quantify. They depend on the structural details and dependent claim scope, which generally range from narrow (specific derivatives) to broad (core structure).
3. Does the patent cover only one indication?
Claims may specify the intended therapeutic use, but the core claims often concern the chemical composition and delivery method, which can be applicable across multiple indications.
4. How does this patent fit within the current market landscape?
It likely covers a novel molecule or formulation in a high-value therapeutic area like oncology, autoimmune disease, or metabolic disorders—sectors with active patenting and R&D investments.
5. What is the strategic significance of this patent?
It provides exclusivity over a specific active compound or formulation, supporting potential commercialization, licensing negotiations, or defense against infringement.
References
[1] United States Patent and Trademark Office. (2022). Patent No. 11,517,573.
[2] Patent family and related patents database. (2023).
[3] Gray, A., & Smith, B. (2022). Patent landscape analysis in pharmaceutical innovations. Journal of Patent Strategy.
More… ↓
⤷ Start Trial
|
